Physician profile
Gary Glazer
NPI 1619991338
$6,251.18
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,886 · 2020: $1,308 · 2021: $1,251 · 2022: $806.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,008.44 | 2019-2022 | |
| Pfizer INC. | $706.45 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $701.53 | 2019-2022 | |
| Novo Nordisk INC | $654.32 | 2019-2022 | |
| Glaxosmithkline, LLC. | $620.23 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $467.62 | 2019-2022 | |
| Abbvie INC. | $373.77 | 2019-2022 | |
| Astellas Pharma US INC | $367.63 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $334.58 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $287.98 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $192.74 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $126.14 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $98.66 | 2019-2022 | |
| Amgen INC. | $75.59 | 2019-2022 | |
| Sanofi Pasteur INC. | $55.93 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.07 | 2020-2021 | |
| Esperion Therapeutics, INC. | $32.05 | 2020 | |
| Sanofi-Aventis U.S. LLC | $23.40 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.10 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.69 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $18.14 | 2021 | |
| Allergan, INC. | $13.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Glazer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.